Cargando…

Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma

INTRODUCTION: Secondary bladder, colon, and rectal cancers are relatively common after prostate radiotherapy. However, secondary squamous cell carcinoma of the prostate is rare. CASE PRESENTATION: An 85‐year‐old man presented with dysuria and low‐serum prostate‐specific antigen levels. His medical h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsugasumi, Toru, Nakanishi, Hiroyuki, Yokota, Tomohiro, Shiraishi, Takumi, Ukimura, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770592/ https://www.ncbi.nlm.nih.gov/pubmed/33392467 http://dx.doi.org/10.1002/iju5.12161

Ejemplares similares

Editorial Comment to Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
por: Uehara, Sho
Publicado: (2020)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
por: Matsugasumi, Toru, et al.
Publicado: (2021)

Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer
por: Ueda, Takashi, et al.
Publicado: (2021)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
por: Matsugasumi, Toru, et al.
Publicado: (2020)

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
por: Narukawa, Tsukasa, et al.
Publicado: (2020)

Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer
por: Narukawa, Tsukasa, et al.
Publicado: (2023)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
por: Ohashi, Toshio, et al.
Publicado: (2014)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015)

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Author Correction: Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
por: Lee, Jeong Won, et al.
Publicado: (2022)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion
por: Shiraishi, Takumi, et al.
Publicado: (2020)

Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment
por: Ichaoui, Hamza, et al.
Publicado: (2019)

Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol
por: Yamada, Yasuhiro, et al.
Publicado: (2019)

Usefulness of bicarbonate Ringer's solution as perfusate during transurethral resection of the prostate
por: Hongo, Fumiya, et al.
Publicado: (2021)

Squamous cell carcinoma of the prostate following treatment with an LHRH–agonist: a rare case of transformation of adenocarcinoma of the prostate
por: Al–Qassim, Zubair, et al.
Publicado: (2014)

Successful treatment with DCF chemotherapy and radiotherapy for primary squamous cell carcinoma of the prostate
por: Atagi, Kaya, et al.
Publicado: (2021)

Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma
por: Barnett, Jack, et al.
Publicado: (2020)

The Efficacy of Radiotherapy without Surgery for External Auditory Canal Squamous Cell Carcinoma
por: Osu, Naoto, et al.
Publicado: (2022)

An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy
por: Gabriele, Domenico, et al.
Publicado: (2021)

Step-by-Step: Fusion-guided prostate biopsy in the diagnosis and surveillance of prostate cancer
por: Nassiri, Nima, et al.
Publicado: (2019)

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: D’Avino, Vittoria, et al.
Publicado: (2015)

Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain
por: Expósito, José, et al.
Publicado: (2015)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients
por: Camps, Saskia M., et al.
Publicado: (2018)

Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
por: Chun, Seok-Joo, et al.
Publicado: (2021)

Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2021)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam Radiotherapy
por: Steed, Tanner, et al.
Publicado: (2023)

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate
por: Roy, Soumyajit, et al.
Publicado: (2023)

Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
por: Inoue, Yuta, et al.
Publicado: (2023)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
por: Tisseverasinghe, Steven A., et al.
Publicado: (2018)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
por: Wang, Henry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dh6pcpp61m2j0miosstdc312fk